Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized L-Asparaginase Dosing in Adult ALL
NCT00136435Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2002
- Primary completion
- Nov 2008
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), sponsored by Dana-Farber Cancer Institute. Started Jun 2002; status: completed.
02
Drugs
asparaginase escherichia coli
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00136435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136435.